Disc Medicine, Inc.

IRON· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$76.31-0.90%

2026-08-03

Financials

Valuation Metrics

Disc Medicine, Inc.'s Market Cap is $2.91B. At end of 2025 it was $2.80B. Ranked #1787 of 3,112 in US market (top 57%), #641 of 1,445 on NASDAQ (top 44%), #107 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 40%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$2.91B	US#1,787/3,112 Sec#107/269
Revenue	$0.00	US#2,974/3,112 Sec#204/269
Net Income	$-246M	US—/3,112 Sec—/269
Total Assets	$735M	US#2,579/3,112 Sec#119/269
Net Assets	$644M	US#2,078/3,112 Sec#86/269
Value
P/B	4.53x	US#2,086/3,112 Sec#131/269
FCF Yield	-6.78%	US—/3,112 Sec—/269
Profitability
ROE	-38.17%	US#2,682/3,112 Sec#148/269
ROA	-33.45%	US#2,890/3,112 Sec#169/269
Financial Health
Debt Ratio	14.11%	US#166/3,112 Sec#69/269
Total Debt	$2M	US#2,913/3,112 Sec#237/269
FCF	$-198M	US#2,728/3,112 Sec#216/269
Cash	$99M	US#2,217/3,112 Sec#178/269
Current Ratio	24.14x	US#105/3,112 Sec#19/269
Performance
1Y Return	29.40%	US#1,273/3,112 Sec#149/269
1M Return	0.07%	US#1,639/3,112 Sec#75/269
From 52W High	-23.31%	US#1,868/3,112 Sec#127/269
1Y MDD	-40.55%	US#1,970/3,112 Sec#147/269
Trading
Volume	280,583 shares	US#2,457/3,112 Sec#240/269
Trading Value	$21M	US#1,922/3,112 Sec#140/269
Per Share
EPS	$-6.01	US—/3,112 Sec—/269
BPS	$20.96	US#1,157/3,112 Sec#31/269